Literature DB >> 2960536

A second signal for T cell mitogenesis provided by monoclonal antibodies CD45 (T200).

J Martorell1, R Vilella, L Borche, I Rojo, J Vives.   

Abstract

The induction of T cell mitogenesis through CD3 is a complex process that requires at least two signals. The first one can be provided by Sepharose-bound CD3. The second one is normally provided by monocytes. The signal provided by Sepharose-bound CD3 is unable by itself to induce mitogenesis in monocyte highly depleted cells (MHDC). We describe here that the monoclonal antibody (mAb) 72-5D3 belonging to CD45 (T200), which was not mitogenic by itself, could replace monocytes when MHDC were activated by Sepharose-bound CD3. That is to say, in the absence of monocytes, mAb 72-5D3 gave a second signal necessary for T cell proliferation. Using eleven anti-CD45 mAb from other investigators we show that this effect is not a peculiar characteristic of 72-5D3 mAb. The effect of the mAb 72-5D3 was only effective in CD4-positive cells and was not observed when MHDC were activated with either soluble CD3 or concanavalin A. As both phorbol myristate acetate and mAb 72-5D3 can replace monocytes, a comparative study of their effects was undertaken. Phorbol myristate acetate but not mAb 72-5D3 induced proliferation of MHDC when recombinant interleukin 2 (rIL2) was added. On the other hand mAb 72-5D3 induced IL2 production in MHDC activated by Sepharose-bound CD3 and increased the IL2 production in Sepharose-bound CD3-activated peripheral blood mononuclear cells. In conclusion, data presented in this report indicate that the T200 molecule could be involved in T cell proliferation by giving a signal that induces the production of IL2 and bypasses the necessity of monocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960536     DOI: 10.1002/eji.1830171010

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

Review 1.  Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation.

Authors:  L T Clement
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

Review 2.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

3.  Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens.

Authors:  J Martorell; J Font; I Rojo; R Vilella; M Ingelmo; J Vives
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

4.  Amplification of T cell blastogenic responses in healthy individuals and patients with acquired immunodeficiency syndrome.

Authors:  P E Harris; K Strba-Cechova; P Rubinstein; D Mann; D W King; N Suciu-Foca
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

5.  Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines.

Authors:  H L Ostergaard; D A Shackelford; T R Hurley; P Johnson; R Hyman; B M Sefton; I S Trowbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Differential effects of CD45 CD45R and CD45R0 monoclonal antibodies in modulating human B cell activation.

Authors:  D L Deane; E Harvey; C M Steel
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

7.  Intimate association of Thy-1 and the T-cell antigen receptor with the CD45 tyrosine phosphatase.

Authors:  S Volarević; C M Burns; J J Sussman; J D Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

8.  The extra segments of sequence in rat leucocyte common antigen (L-CA) are derived by alternative splicing of only three exons and show extensive O-linked glycosylation.

Authors:  D I Jackson; A N Barclay
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

9.  CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells.

Authors:  J A Ledbetter; N K Tonks; E H Fischer; E A Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Effect of Ly 5 allotype on in vitro immune responses.

Authors:  R E Taffs; S J Ewald
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.